Story thread · 15 reports / 3 sources
Moderna is now overvalued after cancer vaccine-led stock surge, Rothschild & Co. says
cnbc.com · 11d
How the coverage leans
Across 3 sources · syndicated copies counted once
The research firm downgraded the biotechnology stock to sell from neutral.
First report: Why is Babcock & Wilcox stock rallying today? — investing.com, 14d
The coverage
- State, federal, local officials celebrate grant signing for $130M Wilcox bridge project
timesfreepress.com · 12d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.